{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:37:18Z","timestamp":1790221038857,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T00:00:00Z","timestamp":1405382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00467-014-2882-8","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T06:49:26Z","timestamp":1405320566000},"page":"1053-1062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Rationale for early treatment of polycystic kidney disease"],"prefix":"10.1007","volume":"30","author":[{"given":"Jared J.","family":"Grantham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,15]]},"reference":[{"key":"2882_CR1","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ (2008) Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 359:1477\u20131485","journal-title":"N Engl J Med"},{"key":"2882_CR2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.00550110","volume":"5","author":"JJ Grantham","year":"2010","unstructured":"Grantham JJ, Cook LT, Wetzel LH, Cadnapaphornchai MA, Bae KT (2010) Evidence of extraordinary growth in the progressive enlargement of renal cysts. Clin J Am Soc Nephrol 5:889\u2013896","journal-title":"Clin J Am Soc Nephrol"},{"key":"2882_CR3","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.1987.121","volume":"31","author":"JJ Grantham","year":"1987","unstructured":"Grantham JJ, Geiser JL, Evan AP (1987) Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int 31:1145\u20131152","journal-title":"Kidney Int"},{"key":"2882_CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/path.2856","volume":"224","author":"H Happe","year":"2011","unstructured":"Happe H, van der Wal AM, Leonhard WN, Kunnen SJ, Breuning MH, de Heer E, Peters DJ (2011) Altered Hippo signalling in polycystic kidney disease. J Pathol 224:133\u2013142","journal-title":"J Pathol"},{"key":"2882_CR5","first-page":"F451","volume":"272","author":"L Geng","year":"1997","unstructured":"Geng L, Segal Y, Pavlova A, Barros EJ, Lohning C, Lu W, Nigam SK, Frischauf AM, Reeders ST, Zhou J (1997) Distribution and developmentally regulated expression of murine polycystin. Am J Physiol 272:F451\u2013F459","journal-title":"Am J Physiol"},{"key":"2882_CR6","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1073\/pnas.86.15.6007","volume":"86","author":"R Mangoo-Karim","year":"1989","unstructured":"Mangoo-Karim R, Uchic M, Lechene C, Grantham JJ (1989) Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc Natl Acad Sci USA 86:6007\u20136011","journal-title":"Proc Natl Acad Sci USA"},{"key":"2882_CR7","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","volume":"66","author":"FA Belibi","year":"2004","unstructured":"Belibi FA, Reif G, Wallace DP, Yamaguchi T, Olsen L, Li H, Helmkamp GM Jr, Grantham JJ (2004) Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int 66:964\u2013973","journal-title":"Kidney Int"},{"key":"2882_CR8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","volume":"1812","author":"DP Wallace","year":"2011","unstructured":"Wallace DP (2011) Cyclic AMP-mediated cyst expansion. Biochim Biophys Acta 1812:1291\u20131300","journal-title":"Biochim Biophys Acta"},{"key":"2882_CR9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ki.1992.405","volume":"42","author":"KD Gardner Jr","year":"1992","unstructured":"Gardner KD Jr, Burnside JS, Skipper BJ, Swan SK, Bennett WM, Connors BA, Evan AP (1992) On the probability that kidneys are different in autosomal dominant polycystic disease. Kidney Int 42:1199\u20131206","journal-title":"Kidney Int"},{"key":"2882_CR10","doi-asserted-by":"crossref","first-page":"F3","DOI":"10.1152\/ajpcell.1983.244.1.C3","volume":"244","author":"JJ Grantham","year":"1983","unstructured":"Grantham JJ (1983) Polycystic kidney disease: a predominance of giant nephrons. Am J Physiol 244:F3\u2013F10","journal-title":"Am J Physiol"},{"key":"2882_CR11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","volume":"7","author":"JJ Grantham","year":"2011","unstructured":"Grantham JJ, Mulamalla S, Swenson-Fields KI (2011) Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 7:556\u2013566","journal-title":"Nat Rev Nephrol"},{"key":"2882_CR12","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ajpath.2014.03.007","volume":"184","author":"CI Galarreta","year":"2014","unstructured":"Galarreta CI, Grantham JJ, Forbes MS, Maser RL, Wallace DP, Chevalier RL (2014) Tubular obstruction leads to progressive proximal tubular injury and atubular glomeruli in polycystic kidney disease. Am J Pathol 184:1957\u20131966","journal-title":"Am J Pathol"},{"key":"2882_CR13","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1046\/j.1523-1755.2002.00689.x","volume":"62","author":"GA Tanner","year":"2002","unstructured":"Tanner GA, Tielker MA, Connors BA, Phillips CL, Tanner JA, Evan AP (2002) Atubular glomeruli in a rat model of polycystic kidney disease. Kidney Int 62:1947\u20131957","journal-title":"Kidney Int"},{"key":"2882_CR14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ki.1996.387","volume":"50","author":"GA Tanner","year":"1996","unstructured":"Tanner GA, Gretz N, Connors BA, Evan AP, Steinhausen M (1996) Role of obstruction in autosomal dominant polycystic kidney disease in rats. Kidney Int 50:873\u2013886","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"2882_CR15","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/s00247-007-0585-z","volume":"38","author":"RL Chevalier","year":"2008","unstructured":"Chevalier RL (2008) Chronic partial ureteral obstruction and the developing kidney. Pediatr Radiol 38[Suppl 1]:S35\u2013S40","journal-title":"Pediatr Radiol"},{"key":"2882_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1681\/ASN.2007080862","volume":"19","author":"RL Chevalier","year":"2008","unstructured":"Chevalier RL, Forbes MS (2008) Generation and evolution of atubular glomeruli in the progression of renal disorders. J Am Soc Nephrol 19:197\u2013206","journal-title":"J Am Soc Nephrol"},{"key":"2882_CR17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-009-1316-5","volume":"25","author":"RL Chevalier","year":"2010","unstructured":"Chevalier RL, Thornhill BA, Forbes MS, Kiley SC (2010) Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr Nephrol 25:687\u2013697","journal-title":"Pediatr Nephrol"},{"key":"2882_CR18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00467-010-1748-y","volume":"26","author":"RL Chevalier","year":"2011","unstructured":"Chevalier RL, Forbes MS, Thornhill BA (2011) Formation of atubular glomeruli in the developing kidney following chronic urinary tract obstruction. Pediatr Nephrol 26:1381\u20131385","journal-title":"Pediatr Nephrol"},{"key":"2882_CR19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00467-013-2590-9","volume":"29","author":"RL Chevalier","year":"2014","unstructured":"Chevalier RL, Forbes MS, Galarreta CI, Thornhill BA (2014) Responses of proximal tubular cells to injury in congenital renal disease: fight or flight. Pediatr Nephrol 29:537\u2013541","journal-title":"Pediatr Nephrol"},{"key":"2882_CR20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ki.2013.501","volume":"85","author":"JM Fonseca","year":"2014","unstructured":"Fonseca JM, Bastos AP, Amaral AG, Sousa MF, Souza LE, Malheiros DM, Piontek K, Irigoyen MC, Watnick TJ, Onuchic LF (2014) Renal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1-deficient mice. Kidney Int 85:1137\u20131150","journal-title":"Kidney Int"},{"key":"2882_CR21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/ki.1989.137","volume":"35","author":"JJ Grantham","year":"1989","unstructured":"Grantham JJ, Uchic M, Cragoe EJ Jr, Kornhaus J, Grantham JA, Donoso V, Mangoo-Karim R, Evan A, McAteer J (1989) Chemical modification of cell proliferation and fluid secretion in renal cysts. Kidney Int 35:1379\u20131389","journal-title":"Kidney Int"},{"key":"2882_CR22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ki.1996.304","volume":"50","author":"CJ Davidow","year":"1996","unstructured":"Davidow CJ, Maser RL, Rome LA, Calvet JP, Grantham JJ (1996) The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. Kidney Int 50:208\u2013218","journal-title":"Kidney Int"},{"key":"2882_CR23","doi-asserted-by":"crossref","first-page":"10206","DOI":"10.1073\/pnas.93.19.10206","volume":"93","author":"SR Brill","year":"1996","unstructured":"Brill SR, Ross KE, Davidow CJ, Ye M, Grantham JJ, Caplan MJ (1996) Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells. Proc Natl Acad Sci USA 93:10206\u201310211","journal-title":"Proc Natl Acad Sci USA"},{"key":"2882_CR24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/pr.2013.191","volume":"75","author":"WE Sweeney Jr","year":"2014","unstructured":"Sweeney WE Jr, Avner ED (2014) Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy. Pediatr Res 75:148\u2013157","journal-title":"Pediatr Res"},{"key":"2882_CR25","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","volume":"64","author":"VE Torres","year":"2003","unstructured":"Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, Frost P, Avner ED (2003) EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int 64:1573\u20131579","journal-title":"Kidney Int"},{"key":"2882_CR26","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP, Investigators C (2006) Volume progression in polycystic kidney disease. N Engl J Med 354:2122\u20132130","journal-title":"N Engl J Med"},{"key":"2882_CR27","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1681\/ASN.2006080835","volume":"17","author":"PC Harris","year":"2006","unstructured":"Harris PC, Bae KT, Rossetti S, Torres VE, Grantham JJ, Chapman AB, Guay-Woodford LM, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, Zhang QJ, Thompson PA, Zhu F, Miller JP (2006) Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 17:3013\u20133019","journal-title":"J Am Soc Nephrol"},{"key":"2882_CR28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2215\/CJN.03780410","volume":"6","author":"MA Cadnapaphornchai","year":"2011","unstructured":"Cadnapaphornchai MA, Masoumi A, Strain JD, McFann K, Schrier RW (2011) Magnetic resonance imaging of kidney and cyst volume in children with ADPKD. Clin J Am Soc Nephrol 6:369\u2013376","journal-title":"Clin J Am Soc Nephrol"},{"key":"2882_CR29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2215\/CJN.00900112","volume":"7","author":"JJ Grantham","year":"2012","unstructured":"Grantham JJ, Mulamalla S, Grantham CJ, Wallace DP, Cook LT, Wetzel LH, Fields TA, Bae KT (2012) Detected renal cysts are tips of the iceberg in adults with ADPKD. Clin J Am Soc Nephrol 7:1087\u20131093","journal-title":"Clin J Am Soc Nephrol"},{"key":"2882_CR30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ki.2011.411","volume":"81","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, Miskulin DC, Steinman TI, Braun WE, Winklhofer FT, Hogan MC, Oskoui FR, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin DR, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Meyers CM, Schrier RW, Group HPS (2012) Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int 81:577\u2013585","journal-title":"Kidney Int"},{"key":"2882_CR31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","volume":"24","author":"VH Gattone 2nd","year":"1999","unstructured":"Gattone VH 2nd, Maser RL, Tian C, Rosenberg JM, Branden MG (1999) Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Dev Genet 24:309\u2013318","journal-title":"Dev Genet"},{"key":"2882_CR32","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","volume":"9","author":"VH Gattone 2nd","year":"2003","unstructured":"Gattone VH 2nd, Wang X, Harris PC, Torres VE (2003) Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9:1323\u20131326","journal-title":"Nat Med"},{"key":"2882_CR33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","volume":"10","author":"VE Torres","year":"2004","unstructured":"Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone VH 2nd (2004) Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med 10:363\u2013364","journal-title":"Nat Med"},{"key":"2882_CR34","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1681\/ASN.2006030251","volume":"17","author":"S Nagao","year":"2006","unstructured":"Nagao S, Nishii K, Katsuyama M, Kurahashi H, Marunouchi T, Takahashi H, Wallace DP (2006) Increased water intake decreases progression of polycystic kidney disease in the PCK rat. J Am Soc Nephrol 17:2220\u20132227","journal-title":"J Am Soc Nephrol"},{"key":"2882_CR35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","volume":"19","author":"X Wang","year":"2008","unstructured":"Wang X, Wu Y, Ward CJ, Harris PC, Torres VE (2008) Vasopressin directly regulates cyst growth in polycystic kidney disease. J Am Soc Nephrol 19:102\u2013108","journal-title":"J Am Soc Nephrol"},{"key":"2882_CR36","doi-asserted-by":"crossref","first-page":"F1089","DOI":"10.1152\/ajprenal.00242.2012","volume":"303","author":"X Wang","year":"2012","unstructured":"Wang X, Ye H, Ward CJ, Chu JY, Masyuk TV, Larusso NF, Harris PC, Chow BK, Torres VE (2012) Insignificant effect of secretin in rodent models of polycystic kidney and liver disease. Am J Physiol Renal Physiol 303:F1089\u2013F1098","journal-title":"Am J Physiol Renal Physiol"},{"key":"2882_CR37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.03250410","volume":"6","author":"VE Torres","year":"2011","unstructured":"Torres VE, Grantham JJ, Chapman AB, Mrug M, Bae KT, King BF Jr, Wetzel LH, Martin D, Lockhart ME, Bennett WM, Moxey-Mims M, Abebe KZ, Lin Y, Bost JE, Consortium for Radiologic Imaging Studies of Polycystic Kidney D (2011) Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6:640\u2013647","journal-title":"Clin J Am Soc Nephrol"},{"key":"2882_CR38","doi-asserted-by":"crossref","first-page":"F1463","DOI":"10.1152\/ajprenal.90266.2008","volume":"295","author":"DP Wallace","year":"2008","unstructured":"Wallace DP, Quante MT, Reif GA, Nivens E, Ahmed F, Hempson SJ, Blanco G, Yamaguchi T (2008) Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor. Am J Physiol Renal Physiol 295:F1463\u2013F1471","journal-title":"Am J Physiol Renal Physiol"},{"key":"2882_CR39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2013.488","volume":"85","author":"DP Wallace","year":"2013","unstructured":"Wallace DP, White C, Savinkova L, Nivens E, Reif GA, Pinto CS, Raman A, Parnell SC, Conway SJ, Fields TA (2013) Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease. Kidney Int 85:845\u2013854","journal-title":"Kidney Int"},{"key":"2882_CR40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2012.446","volume":"83","author":"KI Swenson-Fields","year":"2013","unstructured":"Swenson-Fields KI, Vivian CJ, Salah SM, Peda JD, Davis BM, van Rooijen N, Wallace DP, Fields TA (2013) Macrophages promote polycystic kidney disease progression. Kidney Int 83:855\u2013864","journal-title":"Kidney Int"},{"key":"2882_CR41","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.ASN.0000088720.61783.19","volume":"14","author":"D Zheng","year":"2003","unstructured":"Zheng D, Wolfe M, Cowley BD Jr, Wallace DP, Yamaguchi T, Grantham JJ (2003) Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 14:2588\u20132595","journal-title":"J Am Soc Nephrol"},{"key":"2882_CR42","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","volume":"22","author":"A Karihaloo","year":"2011","unstructured":"Karihaloo A, Koraishy F, Huen SC, Lee Y, Merrick D, Caplan MJ, Somlo S, Cantley LG (2011) Macrophages promote cyst growth in polycystic kidney disease. J Am Soc Nephrol 22:1809\u20131814","journal-title":"J Am Soc Nephrol"},{"key":"2882_CR43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.urology.2007.07.075","volume":"71","author":"N Terada","year":"2008","unstructured":"Terada N, Arai Y, Kinukawa N, Terai A (2008) The 10-year natural history of simple renal cysts. Urology 71:7\u201311, discussion 11-12","journal-title":"Urology"},{"key":"2882_CR44","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/j.1523-1755.2004.00651.x","volume":"65","author":"J Al-Said","year":"2004","unstructured":"Al-Said J, Brumback MA, Moghazi S, Baumgarten DA, O\u2019Neill WC (2004) Reduced renal function in patients with simple renal cysts. Kidney Int 65:2303\u20132308","journal-title":"Kidney Int"},{"key":"2882_CR45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2011.12.022","volume":"59","author":"AD Rule","year":"2012","unstructured":"Rule AD, Sasiwimonphan K, Lieske JC, Keddis MT, Torres VE, Vrtiska TJ (2012) Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors. Am J Kidney Dis 59:611\u2013618","journal-title":"Am J Kidney Dis"},{"key":"2882_CR46","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s004670050343","volume":"11","author":"T Seeman","year":"1997","unstructured":"Seeman T, Sikut M, Konrad M, Vondrichova H, Janda J, Scharer K (1997) Blood pressure and renal function in autosomal dominant polycystic kidney disease. Pediatr Nephrol 11:592\u2013596","journal-title":"Pediatr Nephrol"},{"key":"2882_CR47","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1046\/j.1523-1755.2001.0590051654.x","volume":"59","author":"GM Fick-Brosnahan","year":"2001","unstructured":"Fick-Brosnahan GM, Tran ZV, Johnson AM, Strain JD, Gabow PA (2001) Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int 59:1654\u20131662","journal-title":"Kidney Int"},{"key":"2882_CR48","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/ajkd.2002.33379","volume":"39","author":"GM Fick-Brosnahan","year":"2002","unstructured":"Fick-Brosnahan GM, Belz MM, McFann KK, Johnson AM, Schrier RW (2002) Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am J Kidney Dis 39:1127\u20131134","journal-title":"Am J Kidney Dis"},{"key":"2882_CR49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00126097-200306000-00003","volume":"8","author":"T Seeman","year":"2003","unstructured":"Seeman T, Dusek J, Vondrichova H, Kyncl M, John U, Misselwitz J, Janda J (2003) Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease. Blood Press Monit 8:107\u2013110","journal-title":"Blood Press Monit"},{"key":"2882_CR50","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.ajkd.2013.08.017","volume":"63","author":"DC Miskulin","year":"2014","unstructured":"Miskulin DC, Abebe KZ, Chapman AB, Perrone RD, Steinman TI, Torres VE, Bae KT, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Moore CG, Flessner MF, Schrier RW, Study H-P (2014) Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study. Am J Kidney Dis 63:214\u2013226","journal-title":"Am J Kidney Dis"},{"key":"2882_CR51","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH (1992) Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41:1311\u20131319","journal-title":"Kidney Int"},{"key":"2882_CR52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ki.1989.38","volume":"35","author":"PA Gabow","year":"1989","unstructured":"Gabow PA, Kaehny WD, Johnson AM, Duley IT, Manco-Johnson M, Lezotte DC, Schrier RW (1989) The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int 35:675\u2013680","journal-title":"Kidney Int"},{"key":"2882_CR53","first-page":"629","volume":"53","author":"T Seeman","year":"2004","unstructured":"Seeman T, Dusek J, Vondrak K, Blahova K, Simkova E, Kreisinger J, Dvorak P, Kyncl M, Hribal Z, Janda J (2004) Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease. Physiol Res 53:629\u2013634","journal-title":"Physiol Res"},{"key":"2882_CR54","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2215\/CJN.00360110","volume":"5","author":"E Meijer","year":"2010","unstructured":"Meijer E, Rook M, Tent H, Navis G, van der Jagt EJ, de Jong PE, Gansevoort RT (2010) Early renal abnormalities in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 5:1091\u20131098","journal-title":"Clin J Am Soc Nephrol"},{"key":"2882_CR55","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/ki.1972.78","volume":"2","author":"M Martinez-Maldonado","year":"1972","unstructured":"Martinez-Maldonado M, Yium JJ, Eknoyan G, Suki WN (1972) Adult polycystic kidney disease: studies of the defect in urine concentration. Kidney Int 2:107\u2013113","journal-title":"Kidney Int"},{"key":"2882_CR56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2215\/CJN.00910306","volume":"2","author":"VE Torres","year":"2007","unstructured":"Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP, Consortium for Radiologic Imaging Studies of Polycystic Kidney D (2007) Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2:112\u2013120","journal-title":"Clin J Am Soc Nephrol"},{"key":"2882_CR57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1573402111309010003","volume":"9","author":"O Tkachenko","year":"2013","unstructured":"Tkachenko O, Helal I, Shchekochikhin D, Schrier RW (2013) Renin-Angiotensin-aldosterone system in autosomal dominant polycystic kidney disease. Curr Hypertens Rev 9:12\u201320","journal-title":"Curr Hypertens Rev"},{"key":"2882_CR58","author":"F Rahbari-Oskoui","year":"2014","unstructured":"Rahbari-Oskoui F, Williams O, Chapman A (2014) Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. doi: 10.1093\/ndt\/gft513","journal-title":"Nephrol Dial Transplant"},{"key":"2882_CR59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","volume":"353","author":"N Hateboer","year":"1999","unstructured":"Hateboer N, v Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D (1999) Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 353:103\u2013107","journal-title":"Lancet"},{"key":"2882_CR60","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2215\/CJN.09500911","volume":"7","author":"AB Chapman","year":"2012","unstructured":"Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, Li J, King BF, Martin D, Wetzel LH, Lockhart ME, Harris PC, Moxey-Mims M, Flessner M, Bennett WM, Grantham JJ (2012) Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 7:479\u2013486","journal-title":"Clin J Am Soc Nephrol"},{"key":"2882_CR61","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","volume":"5","author":"S Klahr","year":"1995","unstructured":"Klahr S, Breyer JA, Beck GJ, Dennis VW, Hartman JA, Roth D, Steinman TI, Wang SR, Yamamoto ME (1995) Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J Am Soc Nephrol 5:2037\u20132047","journal-title":"J Am Soc Nephrol"},{"key":"2882_CR62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ki.2013.23","volume":"84","author":"CJ Wang","year":"2013","unstructured":"Wang CJ, Grantham JJ, Wetmore JB (2013) The medicinal use of water in renal disease. Kidney Int 84:45\u201353","journal-title":"Kidney Int"},{"key":"2882_CR63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2008.558","volume":"75","author":"AD Kistler","year":"2009","unstructured":"Kistler AD, Poster D, Krauer F, Weishaupt D, Raina S, Senn O, Binet I, Spanaus K, Wuthrich RP, Serra AL (2009) Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. Kidney Int 75:235\u2013241","journal-title":"Kidney Int"},{"key":"2882_CR64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2215\/CJN.00330705","volume":"1","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Chapman AB, Torres VE (2006) Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol 1:148\u2013157","journal-title":"Clin J Am Soc Nephrol"},{"key":"2882_CR65","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz G, Budde K, Mannaa M, Nurnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Horl WH, Obermuller N, Arns W, Pavenstadt H, Gaedeke J, Buchert M, May C, Gschaidmeier H, Kramer S, Eckardt KU (2010) Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med 363:830\u2013840","journal-title":"N Engl J Med"},{"key":"2882_CR66","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, Rentsch KM, Spanaus KS, Senn O, Kristanto P, Scheffel H, Weishaupt D, Wuthrich RP (2010) Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med 363:820\u2013829","journal-title":"N Engl J Med"},{"key":"2882_CR67","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, Investigators TT (2012) Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367:2407\u20132418","journal-title":"N Engl J Med"},{"key":"2882_CR68","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2215\/CJN.00790209","volume":"4","author":"VE Torres","year":"2009","unstructured":"Torres VE, Bankir L, Grantham JJ (2009) A case for water in the treatment of polycystic kidney disease. Clin J Am Soc Nephrol 4:1140\u20131150","journal-title":"Clin J Am Soc Nephrol"},{"key":"2882_CR69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2215\/CJN.03950510","volume":"6","author":"CJ Wang","year":"2011","unstructured":"Wang CJ, Creed C, Winklhofer FT, Grantham JJ (2011) Water prescription in autosomal dominant polycystic kidney disease: a pilot study. Clin J Am Soc Nephrol 6:192\u2013197","journal-title":"Clin J Am Soc Nephrol"},{"key":"2882_CR70","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1093\/ndt\/gfs152","volume":"27","author":"MC Hogan","year":"2012","unstructured":"Hogan MC, Masyuk TV, Page L, Holmes DR 3rd, Li X, Bergstralh EJ, Irazabal MV, Kim B, King BF, Glockner JF, Larusso NF, Torres VE (2012) Somatostatin analog therapy for severe polycystic liver disease: results after 2 years. Nephrol Dial Transplant 27:3532\u20133539","journal-title":"Nephrol Dial Transplant"},{"key":"2882_CR71","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1136\/gut.2008.155721","volume":"57","author":"L Keimpema van","year":"2008","unstructured":"van Keimpema L, de Man RA, Drenth JP (2008) Somatostatin analogues reduce liver volume in polycystic liver disease. Gut 57:1338\u20131339","journal-title":"Gut"},{"key":"2882_CR72","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","volume":"382","author":"A Caroli","year":"2013","unstructured":"Caroli A, Perico N, Perna A, Antiga L, Brambilla P, Pisani A, Visciano B, Imbriaco M, Messa P, Cerutti R, Dugo M, Cancian L, Buongiorno E, De Pascalis A, Gaspari F, Carrara F, Rubis N, Prandini S, Remuzzi A, Remuzzi G, Ruggenenti P, Group As (2013) Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet 382:1485\u20131495","journal-title":"Lancet"},{"key":"2882_CR73","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0272-6386(95)90497-2","volume":"26","author":"RD Gile","year":"1995","unstructured":"Gile RD, Cowley BD Jr, Gattone VH 2nd, O\u2019Donnell MP, Swan SK, Grantham JJ (1995) Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat. Am J Kidney Dis 26:501\u2013507","journal-title":"Am J Kidney Dis"},{"key":"2882_CR74","doi-asserted-by":"crossref","first-page":"F854","DOI":"10.1152\/ajprenal.00059.2007","volume":"293","author":"I Zafar","year":"2007","unstructured":"Zafar I, Tao Y, Falk S, McFann K, Schrier RW, Edelstein CL (2007) Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model. Am J Physiol Renal Physiol 293:F854\u2013F859","journal-title":"Am J Physiol Renal Physiol"},{"key":"2882_CR75","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.08350813","volume":"9","author":"MA Cadnapaphornchai","year":"2014","unstructured":"Cadnapaphornchai MA, George DM, McFann K, Wang W, Gitomer B, Strain JD, Schrier RW (2014) Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 9:889\u2013896","journal-title":"Clin J Am Soc Nephrol"},{"key":"2882_CR76","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2215\/CJN.04310709","volume":"5","author":"AB Chapman","year":"2010","unstructured":"Chapman AB, Torres VE, Perrone RD, Steinman TI, Bae KT, Miller JP, Miskulin DC, Rahbari Oskoui F, Masoumi A, Hogan MC, Winklhofer FT, Braun W, Thompson PA, Meyers CM, Kelleher C, Schrier RW (2010) The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol 5:102\u2013109","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2882-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-014-2882-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2882-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:30:19Z","timestamp":1649637019000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-014-2882-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,15]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["2882"],"URL":"https:\/\/doi.org\/10.1007\/s00467-014-2882-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,15]]}}}